Question 1

What are the potential benefits of using intramuscular olanzapine depot for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder clinical trial (NCT00088465). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options available for schizophrenia?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder clinical trial (NCT00088465). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of with this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder clinical trial (NCT00088465). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for injections?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder clinical trial (NCT00088465). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I do if I experience any side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder clinical trial (NCT00088465). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any specific eligibility requirements I should be aware of before considering this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder clinical trial (NCT00088465). Contact the study team or your healthcare provider for specific answers.

What this study is about